Cuadrado, A., Kügler, S., & Lastres-Becker, I. (2017). Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy. Redox Biol.
Chicago ZitierstilCuadrado, Antonio, Sebastian Kügler, und Isabel Lastres-Becker. "Pharmacological Targeting of GSK-3 and NRF2 Provides Neuroprotection in a Preclinical Model of Tauopathy." Redox Biol 2017.
MLA ZitierstilCuadrado, Antonio, Sebastian Kügler, und Isabel Lastres-Becker. "Pharmacological Targeting of GSK-3 and NRF2 Provides Neuroprotection in a Preclinical Model of Tauopathy." Redox Biol 2017.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.